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Abstract: Introduction: People with diabetes could have an increased risk of falls as they show
more complications, morbidity and use of medication compared to the general population. This
study aimed to estimate the risk of falls and to identify risk factors associated with falls in people
with diabetes. The second aim was to estimate fall-related injuries, such as lesions and fractures, in-
cluding their anatomic localization in people with diabetes compared with the general population.
Methods: From the Danish National Patient Register, we identified people with Type 1 Diabetes
(T1D) (n=12,975) Type 2 Diabetes (T2D) (n=407,009). The cohort was divided into two groups,
with respective control groups matched on age and sex (1:1). All episodes of people hospitalized
with a first fall from 1996 to 2017 were analyzed using a Cox proportional-hazards model. Risk fac-
tors such as age, sex, diabetic complications, a history of alcohol abuse and the use of medication
were included in an adjusted analysis. The incidence rate, incidence rate difference and incidence
rate ratio (IRR) of falls and the anatomic localization of fall-related injuries as lesions and fractures
were identified.
Results  and  Discussion:  The  cumulative  incidence,  of  falls  requiring  hospital  treatment,  was
13.3% in T1D, 11.9% in T2D. In the adjusted analysis, T1D and T2D were associated with a high-
er risk of falls [T1D, Hazard Ratio (HR): 1.33 (95% CI: 1.25 - 1.43), T2D, HR: 1.19 (95% CI:1.16
-  1.22),  respectively].  Women  [group  1,  HR  1.21  (CI:95%:1.13  -  1.29),  group  2,  HR  1.61
(CI:95%:1.58-1.64)], aged >65 years [groups 1, HR 1.52 (CI:95%:1.39 - 1.61), group 2, HR 1.32
(CI:95%:1.58-1.64)],  use  of  selective  serotonin  receptor  inhibitors  (SSRI)  [group  1,  HR  1.35
(CI:95%:1.1.30  -  1.40),  group  2,  HR  1.32  (CI:95%:1.27-1.38)],  opioids  [group  1,  HR  1.15
(CI:95%:1.12 - 1.19), group 2, HR 1.09 (CI:95%:1.05-1.12)] and a history of alcohol abuse [group
1, HR 1.77 (CI:95%:1.17 - 2.15), group 2, HR 1.88 (CI:95%:1.65-2.15)] were significantly associ-
ated with an increased risk of falls in both groups. The IRR of fall-related injuries as hip, radius,
humerus  and  skull/facial  fractures  were  higher  in  people  with  T2D  than  controls  [IRR  1.02
(CI:95%:1.01-1.04), IRR 1.39 (CI:95%: 1.18-1.61), IRR 1.24 (CI:95%: 1.12-1.37) and IRR 1.15
(CI:95%:1.07-1.24)].  People with T1D had an IRR of  hip fractures [IRR: 1.11 (CI:95%:1.11 –
1.23)].
Conclusion: People with diabetes have an increased risk of first fall and a higher incidence of fal-
l-related injuries,  including fractures.  Advanced aging and sex are  non-modifiable  risk  factors,
whereas diabetes, the use of SSRIs and opioids and alcohol abuse could be potentially modifiable
risk factors for falls. Gaining information on risk factors for falls could guide the management of di-
abetes treatment, i.e., choice of drugs, which enables us to improve treatment, particularly in peo-
ple with a high risk of falls and fractures associated with high mortality.
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1. INTRODUCTION
Falls and fall-related injuries are associated with an in-
creased  risk  of  morbidity  and  mortality  [1].The  World
Health Organisation defines a fall as an event, which results
in  a  person  coming  to  rest  inadvertently  on  the  ground  or
floor or other lower-level [2]. Approximately 20% of people
aged > 65 years and 50% of residents in aged care facilities
fall  annually,  often  repeatedly  [3,  4].  Among  Nordic  cit-
izens, falls are the most frequent unintended fatal incident
[5, 6]. The most common injuries associated with falls are
fractures and lesions. Falling and osteoporosis are the main
determinants of fractures that constitute an increasing public
health burden in aging societies [7]. In particular, type 1 dia-
betes (T1D) and type 2 diabetes (T2D) have been associated
with an increased risk of fractures compared to the general
population [8-11]. In a recent meta-analysis, the relative risk
of any fracture in people with T1D was 3.16 (95% Confi-
dence Interval [CI]:1.51-6.63), but lower among people with
T2D [1.19 (95% CI:1.11-1.27)] [10, 12]. The increased risk
of fractures may be related to decreased bone biomechanical
competence  from  impaired  mineralization  and  bone
turnover,  a  deterioration of  collagen and increased loss  of
calcium in the urine [13-15].
Data on falls among people with diabetes are scarce. Pre-
vious  studies  have  suggested  an  association  between  falls
and diabetes [16-18]. A meta-analysis by Yang et al. found
an increased risk of falls in older people with diabetes com-
pared  with  people  without  diabetes  [RR  1.64  (95%  CI:
1.27-2.11)],  whereas the Maastricht  study reported similar
fall rates in young and well-treated people with T2D com-
pared with healthy people [17, 18]. The first study popula-
tion was limited by only including older people (> 60 years)
and the second by only including people with well-regulated
diabetes. Numerous risk factors for falls could, however, be
more  prevalent  in  people  with  real-life  diabetes,  e.g.,  bal-
ance  and  gait  disturbances,  visual  disability,  changes  in
body composition as sarcopenia, use of drugs and alcohol,
depression and diabetic complication, which could result in
injuries as fractures at different anatomic localization [11].
Gaining information on risk factors for falls could guide the
management of diabetes treatment, i.e., the choice of drugs,
which  could  improve  treatment  outcomes,  particularly  in
people  with  a  high  risk  of  falls  and  fractures.  This  study
aimed to estimate the risk of falls and to identify risk factors
associated with increased falls in people with diabetes com-
pared with the general population. The second aim was to es-
timate  fall-related  injuries,  including  lesions  and  fractures
and their anatomic localization in people with diabetes com-
pared with the general population.
2. MATERIALS AND METHODS
2.1. Source of Data
Data  were  extracted  from  the  Danish  National  Patient
Registry (DNPR). In Danish registries, people are identified
by a unique CPR number [19]. This enabled us to link natio-
nal  data on hospital-diagnoses from the DNPR to the pre-
scribed drug from the register of Medicinal Products Statis-
tics of the Danish Medicines Agency to identify all people
with diabetes residing in Denmark. The DNPR tracks every
hospital admission in Denmark since 1977, recording dates
of admission and discharge. The registry covers 99.4% of all
discharge records from Danish hospitals. It covers all inpa-
tient contacts, outpatient visits to the hospital, outpatient vis-
its to clinics and emergency rooms [20]. Physicians use the
Danish version of the International Classification of Diseas-
es  (ICD)  ICD-8  (from  1977  onwards)  and  10th  revision
(ICD-10)  (from  1994  onwards)  as  part  of  the  National
Health Service Classification System (SKS) to code diagnos-
es.  SKS  keeps  track  of  diagnoses,  symptoms,  health
problems  and  other  causes  of  patient  associated  contacts
with the health services. Information about drug use came
from The National Pharmacological Database by the Danish
Medicines Agency, which is a nationwide register of drugs
sold after 1996 [21].
2.2. Study design and Population
The study was carried out using a retrospective cohort de-
sign. The cohort was comprised of all people older than 20
years of age admitted to hospitals in Denmark between the
1st of January 1996 until the 31st of December 2017. Fig. (1)
shows the numbers and inclusion of people. The cohort was
divided  into  two  groups  with  respective  control  groups
matched on age and sex (1:1); people with T1D (n= 12,975)
and people with T2D (n=407,009). People were stratified in-
to T1D or T2D based on codes from the ICD-10 and drug
treatment according to the Anatomical Therapeutical Chemi-
cal (ATC) classification system. People with T1D were clas-
sified  by  at  least  one  DE10  (type  1  diabetes  mellitus)
ICD-10 code and at least one A10A (insulins and analogs)
and no A10B (blood glucose-lowering drugs, excl. insulins)
ATC codes. They were classified as T2D if they had at least
one  DE11  (type  2  diabetes  mellitus)  ICD-10  code  and  an
A10B  (blood  glucose-lowering  drugs,  excl.  insulins)  or
A10A ATC code. The index date for people with T1D and
T2D was set to the date of the first redeemed prescription of
A10A or A10B, respectively. Each person was followed-up
from his index date until the end of data collection (31 De-
cember 2017), death, the date of emigration or the date of
the outcome of interest, whichever came first. Each control
person was assigned the index date of his matched person
with T1D or T2D.
2.3. Outcome and Exposures
The primary outcome was a person hospitalized with a
first registered event of a fall as the main contact after the
start  of  follow-up  and  risk  factors  associated  with  falls.
From 1996,  a  fall  was  registered  as  “fall  at  ground  level”
[SKS code: EUS00] and “fall from a higher to a lower level”
[SKS code: EUS01]. From 2004 an ongoing fall was regis-
tered as “fall at the same level, from less or higher than 1 me-
ter, unspecified high, other, unspecified” (SKS-codes: EU-
HE00-09). Risk factors were; diabetic complications (diabet-
ic nephropathy [ICD-10: DE102, DE112]diabetic retinopa-
thy [ICD10: DE103, DE113], diabetic neuropathy [ICD-10:
DE104, DE114], peripheral cardiovascular complications to
diabetes [ICD-10: DE105, DE1145], multiple complications
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Fig. (1). The flow of inclusion and number of people enrolled in the study.
to diabetes [ICD-10: DE107, DE117 or > 1 of the mentioned
complications] and other complications to diabetes [ICD-10:
DE106, DE108, DE116, DE118]), drug (opioids [ATC code:
N02A], selective serotonin receptor inhibitors [SSRIs, ATC
code: N06AB] and anxiolytics [ATC code: N05B]) and a his-
tory of alcohol abuse ([CD-10 code: DF10, DZ721]. Diabet-
ic complications were included at the time of the index date.
Dispensing of opioids, SSRIs and anxiolytics was included
at least three months before the start of follow-up to ensure a
current redeemed prescription.
A second outcome was to estimate the anatomic localiza-
tion of fall-related injuries. A fall-related injury was defined
as  a  first  registered  fall  together  with  an  external  injury
event,  which was registered as “lesions and fractures” [D-
S00-99] and comprised of; “lesion or fracture of foot and an-
kle” [SKS code: DS90-99, DS920-929], “lesion or fractures
of hand” [SKS code: DS60-69, DS620-629], “lesion or frac-
ture of hip and femur” [SKS code: DS70-79, DS720-29], “le-
sion  or  fracture  of  the  radius”  [SKS  code:  DS50-59,
DS520-29], “lesion or fracture of the humerus” [SKS code:
DS40-49,  DS420-29],  “lesion  or  fracture  of  the  pelvis”
[SKS code:  DS30-39,  320-329],  “lesion  of  fracture  of  the
skull/face” [SKS code: DS00-09, DS002-029] and “lesions
of  fracture  of  the  thorax”  [SKS-code:  DS20-29,
DS220-229].
2.4. Statistical analyses
A histogram and a qq-plot were used to examine continu-
ous variables for normal distribution. If data were not nor-
mally distributed, log transformation was applied. Descrip-
tive statistics were presented with a mean or percentage of
people with a p-value to show statistical significance. Data
was  tested  using  an  un-paired  T-test  to  compare  variables
within the groups.  Non-parametric  data were expressed as
median  (range).  The  Wilcoxon  rank-sum test  was  used  to
compare nonparametric data within the groups.
A Cox-proportional hazards model was applied to ana-
lyze  the  adjusted  and  unadjusted  effect  of  falls  with  T1D
and T2D versus controls. Covariates and risk factors in the
adjusted model included sex, age, diabetes duration, diabetic
complications, a history of alcohol abuse and the use of SS-
RIs, opioids, and anxiolytics. The Cox-proportional hazards
assumption was checked by a parallel log-log transformation
of the two survival curves and by a proportional fitted survi-
val curve.
The incidence rates (IR), incidence rate difference (IRD)
and the incidence rate ratios (IRR) of the first fall, fall-relat-
ed injury events as lesions and fractures at specific anatomic
localization were estimated from the index-date to the first
event  of  fall  or  fall-related  injury  for  people  with  T1D or
T2D compared to controls.
The  analyses  were  conducted  in  STATA version  16.0.
The significance level was set at a p-value of less than 0.05
for two-sided testing.
3. RESULTS
Table  1  shows  the  characteristics  of  people  with  T1D
(n=12,975), T2D (n=407,009) and the matched controls at
the index-date. The mean age was lower in people with T1D
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Table 1. Characteristics at baseline for people with T1D and sex- and age-matched (group 1) and T2D and sex- and age-matched
(group 2) enrolled in this study.
Group 1 Group 2
Variable T1D Controls P T2D Controls P
Number of people 12,975 12,975 Matched 407,009 407,009 Matched
Sex (%)
Women 4,780 (36.8) 4,781 (36.8) Matched 201,718 (49.6) 201,718 (49.6) Matched
Men 8,195 (63.2) 8,196 (63.2) Matched 205,291 (50.4) 205,291 (50.4) Matched
Age, years (mean or median) 49.3 49.3 Matched 58.2 58.2 Matched
Age interval, (%)
Age > 20 and age < 65 9,841 (75.85) 9,841 (75.85) Matched 256,232 (62.95) 256,232(62.95) Matched
Age > 65 3,134 (24.15) 3,134 (24.15) Matched 150,777 (37.05) 150,777(37.05) Matched
Exposure time, years (mean or median) 7.55 9.71 <0.001 7.60 8.31 <0.001
Falls (%)
All falls 2,500 (19.3) 2,346 (18.0) <0.001 67,600 (16.6) 63,759 (15.70) <0.001
First fall from diagnosis 1,726 (13.3) 1,687 (13.0) <0.001 48,553 (11.9) 46,497 (11.42) <0.001
A history of diabetic Complications (%)
Cardiovascular 98 (0.7) 0 - 1,637 (0.4) 0 -
Nephropathies 97 (0.6) 0 - 1,416 (0.3) 0 -
Neuropathy 77 (0.6) 0 - 1,801 (0.4) 0 -
Retinopathy 45 (0.3) 0 - 482 (0.1) 0 -
Multible 88 (0.7) 0 - 927 (0.2) 0 -
Others 665 (5.0) 0 - 8,125 (2.0) 0 -
Medication prior to baseline (%)a
Opioids 1,057 (8.2) 173 (1.3) <0.001 27,486 (6.8) 8,624 (2.1) <0.001
Anxiolytics 446 (3.4) 158 (1.2) <0.001 14,530(3.6) 5,788 (1.4) <0.001
SSRIs 353 (2.7) 129 (1.0) <0.001 16,449 (4.0) 6,292 (1.5) <0.001
Opioids and Anxiolytics 247 (1.9) 31 (0.2) <0.001 4,805 (1.2) 1,281 (0.3) <0.001
SSRIs and Opioids 156 (1.3) 23 (0.2) <0.001 4,993 (1.2) 1,297 (0.3) <0.001
SSRIs and Anxiolytics 75 (0.6) 23 (0.2) <0.001 3,331 (0.8) 1,109 (0.3) <0.001
SSRIs, Opioids and Anxiolytics 62 (0.5) 6 (0.0) <0.001 1,498 (0.4) 319 (0.1) <0.001
A history of alcohol abuse (%) 83 (0.6) 10 (0.01) <0.001 823 (0.2) 379 (0.01) <0.001
(49 years) than people with T2D (58 years). A higher propor-
tion of men than women had T1D (63.2%), but the sex distri-
bution  was  balanced in  T2D (50.5%).  Between 10 and 15
percent of all people suffered a first fall during the years of
exposure  (T1D=13.3%  vs  control=13.0%,  p=<0.001  and
T2D=11.9% vs control=11.42%, p<0.001). History of diabet-
ic complications was low at baseline, but similar among peo-
ple with T1D and T2D. The use of opioids was 3- to 6-fold
higher  (T1D=  8.2%  vs  controls=1.3%,  p=<0.001  and
T2D=6.8% vs  controls=2.1%,  p<0.001).  People  with  T1D
(0.6%) showed a higher proportion of previous diagnoses of
alcohol abuse than T2D (0.01%).
The Cox proportion assumption was not violated (Table
2). In the adjusted analysis, both T1D and T2D were associ-
ated  with  an  increased  risk  of  falls  [T1D,  HR  1.33
(CI:95%:1.25  -  1.43)  and  T2D,  HR  1.19  (CI:95%:1.16  -
1.22), respectively]. In both groups, women were more like-
ly to suffer from a fall compared to men [group 1, HR 1.21
(CI:95%:1.13  -  1.29),  group  2,  HR  1.61  (CI:95%:
1.58-1.64)]. No significant association was seen regarding di-
abetic complications at baseline and the risk of falls in either
group [group 1, HR 0.96 (CI95%:0.81-1.21), group 2, HR
1.04 (CI95%:0.96-1.10)]. Recent use of SSRIs was associat-
ed with falls in both groups [group 1, HR 1.35 (CI:95%:1.30
- 1.40), group 2, HR 1.32 (CI:95%:1.27 - 1.38)], while re-
cent use of opioids yielded an HR 1.15 (CI:95%:1.12 - 1.19)
in group 1 and HR 1.09 (CI:95%:1.05 - 1.12) in group 2, re-
spectively. Concomitant use of SSRIs and opioids further in-
creased the risk of  falls  in both groups [group 1,  HR 1.92
(CI95%:1.31-2.84), group 2 HR 1.60 [(CI95%:1.49-1.73)].
However, a similar association was not seen with the recent
use  of  anxiolytics.  A  previous  history  of  alcohol  abuse
showed a significant increase in the risk of falls [group 1 HR
1.77  (CI:95%:1.17  -  2.15),  group  2,  HR  1.88
(CI95%:1.65-2.15)].
Table 3 shows the IR, IRD and the IRRs of the first falls
and  fall-related  injuries  including  lesions  and  fractures  in
people  with  T1D  and  T2D  compared  to  controls.  This
showed  a  higher  difference  in  incidence  per  1,000  person
years (PYs) in people with T1D and T2D for a first fall and
fall-related  injuries  (T1D,  IRD  12.2  and  6.23,  p<0.001,
T2D, IRD 5.25 and 3.36, p<0.001). Also, a higher incidence
A Nationwide Cohort Study Current Drug Safety, 2020, Vol. 15, No. 00   5
Table 2. Adjusted and unadjusted results from the Cox regression analysis for people with T1D and sex- and age-matched (group 1)
and T2D and sex- and age-matched (group 2) and the risk of falls.
Group 1 Group 2
Exposure HR (95%CI) P HR (95%CI) P
Unadjusted risk of falls
T1D 1.19 (1.15-1.34) <0.001 - -
T2D - - 1.09 (1.07-1.1) <0.001
Controls 1 - 1 -
Adjusted risk of falls
T1D 1.33 (1.25-1.43) <0.001 - -
T2D - - 1.19 (1.16-1.22) <0.001
Controls 1 - 1 -
Age
Age > 65 1.52 (1.39-1.61) <0.001 1.32 (1.30-1.35) <0.001
Age > 20 < 65 1 - 1 -
Sex
Women 1.21 (1.13-1.29) <0.001 1.61 (1.58-1.64) <0.001
Male 1 - 1 -
A history of diabetic complications 0.96 (0.81 - 1.21) 0.465 1.04 (0.96 - 1.10) 0.056
A history of medication
SSRI 1.35 (1.30 - 1.40) <0.001 1.32 (1.27 - 1.38) <0.001
Opiods 1.15 (1.12 - 1.19) <0.001 1.09 (1.05 - 1.12) <0.001
Anxiolytics 0.97 (0.89 - 1.33) 0.184 0.98 (0.89 - 1.12) 0.184
SSRI and Opiods 1.92 (1.31 - 2.84) 0.001 1.60 (1.49 - 1.73) <0.001
SSRI and anxiolytics 0.93 (0.57 - 1.53) 0.794 1.15 (1.07 - 1.21) 0.012
Anxiolytics and opiods 0.93 (0.68 - 1.27) 0.654 1.03 (0.97 - 1.10) 0.329
SSRI, anxiolytics and opiods 1.09 (1.05 - 1.21) <0.001 1.14 (1.08 - 1.21) <0.001
A history of Alcohol abuse 1.77 (1.17 - 2.15) 0.006 1.88 (1.65 - 2.15)
<0.001



























First fall 1,726 1,687 68.75 56.55 1.21 (1.13 - 1.29) 48,553 46,497 64.56 59.31 1.09(1.07 - 1.12)
First fall-related
injury 695 620 36.6 29.2 1.25 (1.12 - 1.39) 13.236 12.197 23.59 21.04 1.10 (1.07 - 1.12)
Fall-related injuries by anatomic localization
Ankle and foot 84 93 5.51 4.62 1.19 (0.98 - 2.07) 1,270 1,185 2.24 2.18 1.03 (0.93 - 1.11)
Hand 70 76 4.44 3.97 1.11 (0.90 - 1.19) 1,416 1,342 2.60 2.48 1.04 (0.96 - 1.10)
Hip and femur 101 86 4.20 3.61 1.16 (0.83 - 1-63) 2,037 1,750 3.35 3.10 1.08 (1.04 - 1.11)
Radius 78 69 4.09 3.27 1.25 (0.88 - 1.75) 1,699 1,480 3,29 2.39 1.37 (1.27 - 1.47)
Humerus 92 68 4.03 3.83 1.05 (0.75 - 1.45) 1,505 1,412 2.73 2.43 1.12 (1.04 - 1.20)
Pelvis and lower
back 28 20 1.18 1.20 0.98 (0.52 - 1.80) 580 489 0.94 0.94 1.00 (0.88 - 1.13)
Skullfacial 114 106 6.04 4.73 1.27 (0.96 - 1.68) 2,422 2,285 4.33 3.82 1.13 (1.06 - 1.20)
Thorax and up-
per-back 25 35 1.89 1.20 0.57 (0.91 - 2.71) 538 515 0.99 0.86 1.14 (0.98 - 1.32)
Fractures by anatomic localization
Ankle and foot 21 12 0.71 0.90 0.78 (0.35 - 1.67) 180 207 0.30 0.40 0.75 (0.56 - 1.30)
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Hand 28 24 1.42 1.20 1.18 (0.65 - 2.11) 474 437 0.84 0.76 1.10 (0.96 - 1.25)
Hip and femur 58 47 2.78 2.49 1.11 (1.02 - 1-23) 1,421 1,207 2.33 2.28 1.02 (1.01 - 1.04)
Radius 56 41 2.43 2.23 1.04 (0.67 - 1.59) 1,313 1,069 1.81 1.31 1.39 (1.28 - 1.51)
Humerus 61 29 1.71 2.23 0.65 (0.40 - 1.03) 774 803 1.55 1.25 1.24 (1.12 - 1.37)
Pelvis and lower
back 7 9 0.29 0.12 2.29 (0.44 - 14.77) 205 196 0.01 0.11 0.90 (0.62 - 1.35)
Skull/facial 87 83 3.49 2.75 1.26 (0.86 - 1.87) 1,107 1,160 2.80 2.42 1.15 (1.07 - 1.24)
Thorax and upper
back 8 12 0.71 0.34 2.06 (0.77 - 5.43) 136 121 0.18 0.14 1.27 (0.92 - 1.68)
of  first  falls  in  people  with  diabetes  [T1D,  IRR  1.21
(CI:95%:1.13 – 1.29), T2D, IRR 1.09 (CI:95%:1.07 - 1.12)]
was seen. The incidence of fall-related injuries was higher in
both T1D and T2D [T1D, IRR 1.16 (CI:95%:1.08 – 1.24),
T2D, IRR 1.12 (CI:95%:1.09 – 1.15)]]. Regarding fall-relat-
ed  injuries  at  specific  anatomic  localization,  people  with
T1D had a higher incidence of hip and femur fractures [IRR:
1.11 (CI:95%:1.11 – 1.23)]. The IRR of fall-related injuries
as hip, radius, humerus and skull/facial fractures were high-
er  in  people  with  T2D  than  controls  [IRR  1.02
(CI:95%:1.01-1.04),  IRR  1.39  (CI:95%:  1.18-1.61),  IRR
1.24  (CI:95%:  1.12-1.37)  and  IRR  1.15  (CI:95%:
1.07-1.24)]. Non-significant increased risk of fractures was
seen at other anatomic localizations.
4. DISCUSSION
In this population-based retrospective cohort study, we
used nationwide data to estimate the incidence of falls, risk
factors and fall-related injures, including fractures for falls
in people with diabetes during the period 1996-2017 that re-
quired  acute  medical  attention.  The  risk  of  falls  was  in-
creased in people with T1D and T2D compared to matched
controls. Several risk factors such as age, female gender, re-
cent use of SSRIs or opioids and a history of alcohol abuse
were  associated  with  an  increased  risk  of  falls.  The  inci-
dence of hip, femur, radius, humerus and head lesions and
fractures was significantly increased in T2D.
4.1. Fall-related injuries
A high overall incidence was reported as approximately
10-15% of all people with diabetes had suffered a hospital-
ized fall within the 20 years study period. However, the accu-
rate estimate of falls is most likely underestimated due to un-
reported  falls  not  leading  to  hospitalization  or  falls  with
another  origin  than  injuries,  e.g.,  lipothymia  or  epilepsy
(SKS codes: DR55 “fainting and collapse”, DG20 “epilep-
sy”). The ICD-10 codes are categorized differently than fal-
l-related injuries and the correlation with falls is not yet vali-
dated.  The  majority  of  falls  in  a  nursing  home  are  unwit-
nessed  [22].  Falls  could  be  unreported  if  the  resident  was
able to rise without assistance, then the fall or injury would
not be reported. Our findings of a higher incidence of falls
in people with diabetes resemble the findings of Vestergaard
et  al.,  who reported higher risks of  fractures,  especially at
the hip [10, 12]. In particular, hip and femoral fractures in
people with diabetes were also shown to have an increased
incidence rate ratio in this study. Especially, hip and femoral
fractures are associated with an increased risk of mortality
and are a huge burden to society [23]. Head injuries were al-
so  increased  and  the  anatomic  localization  could  indicate
that people with T2D suffer more from episodes with loss of
conscience,  arrhythmia,  or  hypoglycemia.  Furthermore,
head injuries or traumatic brain injuries are associated with
complications  as  intracerebral  hemorrhage,  brain  damage,
and  meningitis,  which  require  complex  treatment  [24].
Pelvic injuries are often associated with falls in the elderly
population and have a high complication rate and risk of rup-
tures  of  vessels,  which  is  the  primary  cause  of  death  [25,
26]. To fend-off a fall, a well-balanced postural control sys-
tem is needed. Fractures at the humerus and radius could in-
dicate  another  falling  mechanism  from  a  lack  of  reflexes,
e.g., neuropathy or a compromised cardiovascular response,
hence falling on the side.
4.2. Risk factors
Drugs used in people with diabetes could be a potential-
ly modifiable risk factor for falls [27, 28]. Treatment with
SSRIs,  opioids,  and  anxiolytics  was  commonly  used
amongst people with diabetes. SSRIs have been associated
with  a  1.4-  to  6-fold  increased  risk  of  falls  [29].  Further-
more, treatment with SSRIs in combination with opioids has
shown  an  increased  risk  of  developing  serotonergic  syn-
drome, hyponatremia, and an increase in blood sugar, unap-
propriated effects on the central nervous system or cardiovas-
cular system that could increase the risk of falls by postural
imbalance  [30].  Treatment  with  SSRIs  is  mainly  used  to
treat depression and is rarely indicated in the treatment of di-
abetic neuropathy [31]. In addition, only a few people were
diagnosed at baseline with neuropathy, hence this was proba-
bly not the indication for the prescription, but most likely de-
pression. A meta-analysis showed a higher level of depres-
sive symptoms resulted in a great  risk of falling [RR 1.52
(95%  CI:1.19-  1.84)]  [32].  Another  recent  meta-analysis
showed that one out of four people with T2D experienced de-
pression, and depressive symptoms were found to be consis-
tently associated with falls in older people [33]. Hence, the
excessive use of SSRIs could be an expression of depression
in people with diabetes in this study.
Up to 50% of people with diabetes develop diabetic neu-
ropathy  and  about  20%  develop  painful  neuropathic  [34].
Opioids are frequently used as a last resort against painful
neuropathy.  In  a  recent  case-control  study of  people older
than 65 years, the use of opioids one month before a fall was
significantly associated with a greater risk of suffering a fall
with hip fracture [OR 4.49 (95%CI:2.72-7.42)] [35]. These
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findings correspond to the findings in this study and add to
the long list of side-effects from opioid use, which should be
considered carefully, especially in the management of peo-
ple with a chronic illness like diabetes.
The use of anxiolytics showed no significant association
with falls, though anxiolytics may increase the risk of falling
due to the risk of occurrence of drowsiness, muscle weak-
ness, change in stability, vertigo, and hypotension [36]. How-
ever, the indication for anxiolytics varies from sleeping dis-
orders, epilepsy, drug addiction to epilepsy and neurological
disputes and differs in concentration, mechanism of action,
and duration [36]. Hence, identifying the entities and use of
the drugs, specific types of anxiolytics could also have in-
creased the risk of falls in this study.
In this study, the combination of different drugs addition-
ally increased the risk of falls. In general, there is clear evi-
dence that polypharmacy increases the risk of falls [37]. A
study by Huang et al. showed that regimens including 4 or
more prescribed drugs were significantly associated with an
increased risk of falling [4-5 drugs, HR 1.22 (95% CI: 1.04 -
1.43)],  [6-7  drugs,  1.33  (95% CI:  1.12  -  1.58),  [>7  drugs,
1.59 (95% CI: 1.34, 1.89)] [38]. People with T2D take, on
average, nine prescription drugs compared to four prescrip-
tion  drugs  in  people  without  diabetes  [16].  Polypharmacy
might be an indication of intensified treatment due to a wors-
ening of the diabetes condition. However, the awareness of
particular harmful drugs, as included in this study, should be
considered carefully in the management of people with dia-
betes.
The elderly population is associated with numerous risk
factors for falls, and diabetes seems to add to the increased
risk, but also at a younger age. Especially, people with T1D
are diagnosed at a younger age, i.e., longer diabetes duration
and risk of developing complications that require pharmaco-
logical treatment and episodes of hypoglycemia.
People  with  a  previous  history  of  alcohol  abuse  were
highly associated with an increased risk of falls.  Amongst
others, alcohol increases the risk of hyponatremia, dehydra-
tion, liver diseases, and neuropathy, which affects the chemi-
cal and compensatory mechanisms necessary to avoid a fall
[39].  Besides  the  risk  of  falls,  several  mechanisms  exist
whereby  alcohol  might  also  adversely  affect  the  fracture
risk. A recent study showed a 3-fold increase of fractures in
people with diabetes associated with an alcohol-related diag-
nosis [40]. Over time, alcohol decreases bone turnover due
to malabsorption, malnutrition, and metabolic effects from
alcohol resulting in calcium deficits, which could increase
the risk of fractures [41, 42]. The negative effects of exten-
sive  use  of  alcohol  could  be  more  pronounced  in  people
with diabetes compared to people without diabetes. There-
fore, alcohol should be considered an important risk factor
of falls and fractures in diabetes; especially, when consid-
ered the higher proportion of people with diabetes with a his-
tory of alcohol abuse compared with the general population.
However, the proportion of alcohol abuse was probably un-
derestimated compared with other study findings [43].
Complications to diabetes were low at the time of diagno-
sis  and  a  non-significant  association  with  the  risk  of  falls
was  seen.  The  proportion  of  people  who  develop  diabetic
complications as reduced eyesight, neuropathic pain, or car-
diovascular increases over time and could potentially be risk
factors for falls.
Following the present results, others have found injury--
causing falls, leading to medical treatment to be overrepre-
sented in women compared with men [44, 45]. Women also
have an increased risk of fractures, probably due to hormon-
al factors like a lack of estrogen following menopause [25,
46, 47]. Hormonal factors may also affect the loss of muscle
mass, and in several studies, it has been shown that women
tend to lose muscle strength faster than men [48, 49]. Sever-
al studies have reported a decrease in muscle mass, strength,
and function in people with diabetes compared with people
without diabetes [50, 51]. If loss of balance occurs, prevent-
ing a fall may become challenging due to inadequate muscle
response and fall-related injuries could increase. Hence, wo-
men with diabetes and advanced aging seem to be at a partic-
ularly increased risk for falls and fall-related injuries as frac-
tures.
4.3. Strengths
This study has several advantages for addressing the as-
sociation of falls and fractures in diabetes.  This cohort al-
lows for population-based estimates of incidences, risk as-
sessments, and characterization of falls in people with dia-
betes. Besides, matched control groups represent the general
population, which allows us to make robust risk estimations.
In  addition,  comprehensive  adjustments  reduced  the  con-
founding risk factors associated with falls as age, sex, alco-
hol abuse, drugs, diabetes duration and diabetes type. A pre-
vious  validation  study  of  the  accuracy  of  DNHR  records
from somatic hospital departments showed that the contact
reasons and the injury mechanisms were correctly coded in
more than 90% of the validated records [52].
5. LIMITATIONS
In this study, people with T1D and T2D both showed an
increased risk of falls compared to controls. However, some
limitations have to be considered. Firstly, additional adjust-
ment for body mass index (BMI), other types of drugs, previ-
ous falls and fractures were not added to the analysis, due to
the  restricted  access  to  patient  records.  In  general,  under-
weight is thought to increase the risk of falls due to sarcope-
nia, fatigue, and malnutrition [53, 54]. However, the majori-
ty  of  people  with  diabetes  are  often  overweight,  though
weight loss often occurs in people with T1D before diagno-
sis [55].
Secondly,  ICD-10  codes  were  used  to  identify  falls.
From 1987  to  2004,  all  falls  were  coded  according  to  the
NOMESCO  (NOrdic  MEdico-Statistical  COmmittee)  in-
jury-code system, which describes the external cause of the
injury, place of occurrence of the injury, and the activity per-
formed at the time of injury [56]. From 2004 and onwards,
the NOMESCO injury-code system was replaced by other
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SKS-codes, and the validity of fall codes could have been re-
duced. However, it would probably underestimate the effect
of falls. Moreover, 50% of all fall-related injuries recorded
in the DNHR were unspecified according to the activity per-
formed at the time of the fall incident; hence no attempt was
made to characterize the fall injury events by this informa-
tion. Moreover, the activity was not included as an endpoint
in this study set-up.
CONCLUSION
In  conclusion,  this  study  showed  a  high  overall  inci-
dence of falls in people with diabetes resulting in hospitaliza-
tion. Besides, several risk factors were associated with falls,
like age, female gender, SSRIs, opioids, and a history of al-
cohol  abuse.  Hip,  radius,  humerus  and  head  injuries  were
more pronounced in people with T2D.
Advanced aging and sex are non-modifiable risk factors,
whereas diabetes, drugs, and alcohol abuse could be a poten-
tially modifiable risk factor for falls. Gaining information on
risk factors for falls could guide the management of diabetes
treatment, i.e., choice of drug, which enables us to improve
treatment, particularly in people with a high risk of falls and
fractures associated with high mortality.
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